Michelle M Foisy

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. doi request reprint Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
    M M Foisy
    Royal Alexandra Hospital, Northern Alberta HIV Program, Edmonton, Alberta, Canada
    HIV Med 9:389-96. 2008
  2. doi request reprint Induction effects of ritonavir: implications for drug interactions
    Michelle M Foisy
    Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:1048-59. 2008
  3. doi request reprint Abacavir hypersensitivity reaction: an update
    Christine A Hughes
    Faculty of Pharmacy and Pharmaceutical Sciences, HIV, Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Region, Edmonton, Alberta, Canada
    Ann Pharmacother 42:387-96. 2008
  4. doi request reprint Complexity of interactions between voriconazole and antiretroviral agents
    Erin M Yakiwchuk
    Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:698-703. 2008
  5. doi request reprint Adverse effects of antiretrovirals in HIV-infected pregnant women
    Dalyce M Zuk
    Regional Pharmacy Services, Capital Health, Edmonton, Alberta, Canada
    Ann Pharmacother 43:1028-35. 2009
  6. doi request reprint Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir
    Jill J Hall
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Int J STD AIDS 24:748-52. 2013
  7. ncbi request reprint Pharmaceutical care for HIV patients on directly observed therapy
    Michelle M Foisy
    Northern Alberta HIV Program, Royal Alexandra Hospital and DOT for HAART Program, Boyle McCauley Health Centre, Edmonton, Alberta, Canada
    Ann Pharmacother 38:550-6. 2004

Collaborators

Detail Information

Publications7

  1. doi request reprint Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
    M M Foisy
    Royal Alexandra Hospital, Northern Alberta HIV Program, Edmonton, Alberta, Canada
    HIV Med 9:389-96. 2008
    ..The clinical presentation, diagnosis and management will be discussed...
  2. doi request reprint Induction effects of ritonavir: implications for drug interactions
    Michelle M Foisy
    Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:1048-59. 2008
    ..To review the literature on the induction effects of ritonavir on the cytochrome P450 enzyme system and glucuronyl transferase and identify resultant established and potential drug interactions...
  3. doi request reprint Abacavir hypersensitivity reaction: an update
    Christine A Hughes
    Faculty of Pharmacy and Pharmaceutical Sciences, HIV, Northern Alberta HIV Program and Regional Pharmacy Services, Capital Health Region, Edmonton, Alberta, Canada
    Ann Pharmacother 42:387-96. 2008
    ..To review the clinical features, risk factors, diagnosis, and management of abacavir hypersensitivity reaction (HSR)...
  4. doi request reprint Complexity of interactions between voriconazole and antiretroviral agents
    Erin M Yakiwchuk
    Regional Pharmacy Services, Capital Health Authority, Edmonton, Alberta, Canada
    Ann Pharmacother 42:698-703. 2008
    ..To evaluate and summarize pertinent aspects of the literature on interactions between voriconazole and antiretroviral agents...
  5. doi request reprint Adverse effects of antiretrovirals in HIV-infected pregnant women
    Dalyce M Zuk
    Regional Pharmacy Services, Capital Health, Edmonton, Alberta, Canada
    Ann Pharmacother 43:1028-35. 2009
    ..It is unclear whether the risk of ARV-related adverse drug reactions (ADRs) is increased during pregnancy...
  6. doi request reprint Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir
    Jill J Hall
    Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
    Int J STD AIDS 24:748-52. 2013
    ..We review the probable mechanism for this interaction and describe similar cases of Cushing syndrome in patients receiving concomitant ritonavir and triamcinolone. ..
  7. ncbi request reprint Pharmaceutical care for HIV patients on directly observed therapy
    Michelle M Foisy
    Northern Alberta HIV Program, Royal Alexandra Hospital and DOT for HAART Program, Boyle McCauley Health Centre, Edmonton, Alberta, Canada
    Ann Pharmacother 38:550-6. 2004
    ..A multidisciplinary team including the pharmacist can impact upon the delivery of care to the inner-city HIV patient population...